U.S. Investing Ideas

US$17.23
61.5% undervalued intrinsic discount
Profit Margin
25%
Future PE
34.3x
Price in 2031
US$25.63
US$220
35.3% undervalued intrinsic discount
Fair Value
Revenue
9.64% p.a.
Profit Margin
14.22%
Future PE
10.42x
Price in 2036
US$512.69
ELTX logo
Elicio Therapeutics

Very Bullish

98% of pancreatic cancer patients in Phase II study generated powerful immune responses to the KRAS antigens. Median T-cell immune response above threshold was 44-fold.Read more

View narrative
US$100
89.2% undervalued intrinsic discount
Fair Value
Profit Margin
21.21%
Future PE
29.38x
Price in 2031
US$140.1
US$94.33
2.3% overvalued intrinsic discount
Fair Value
Profit Margin
24.93%
Future PE
29.37x
Price in 2031
US$0
GIFT logo
Giftify

Giftify: 10K Analyse

Giftify, Inc. (NASDAQ: GIFT) Price Target: $0.00 The Lead: The Systematic Draining of Shareholders Before we look at the operations, we must look at the math of ownership.Read more

View narrative
US$0
n/aintrinsic discount
Fair Value
Profit Margin
12.13%
Future PE
20.29x
Price in 2031
US$3.07